Cambridge Investment Research Advisors
SBAR

Cambridge Investment Research Advisors’s Simplify Barrier Income ETF SBAR Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SBAR Stock Details SBAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Buy
+32,957
New +$838K ﹤0.01% 2461

Other funds holding SBAR

PCS
Private Client Services Louisville, Kentucky $381M AUM 24.56% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
KCM
Key Capital Management Hendersonville, Tn 37075, Tennessee $194M AUM
SB
Strategic Blueprint Atlanta, Georgia $2B AUM 27.02% 1-Year Est. Return
RA
RiverTree Advisors Winter Park, Florida $169M AUM 10.14% 1-Year Est. Return
BIG
Brookwood Investment Group Phoenix, Arizona $888M AUM 32.21% 1-Year Est. Return
BOSSRA
B.O.S.S. Retirement Advisors Lehi, Utah $370M AUM 21.67% 1-Year Est. Return
PEA
Park Edge Advisors Cleveland, Ohio $475M AUM 23.17% 1-Year Est. Return
NA
Networth Advisors Canonsburg, Pennsylvania $172M AUM
PFA
Professional Financial Advisors North Platte, Nebraska $578M AUM 19.5% 1-Year Est. Return

Cambridge Investment Research Advisors's SBAR Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Simplify Barrier Income ETF (SBAR) in Q2 2026: 32,957 shares worth $844K. The stake represents ﹤0.01% of the portfolio and ranks #2461 among its holdings.

31 funds tracked by Wall St. Rank hold SBAR as of Q2 2026.

  • Cambridge Investment Research Advisors held 32,957 shares of Simplify Barrier Income ETF worth $844K as of Q2 2026.
  • Simplify Barrier Income ETF was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Simplify Barrier Income ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2461 holding.
  • 31 funds tracked by Wall St. Rank held Simplify Barrier Income ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.